ArticleClinical cancer research : an official journal of the American Association for Cancer Research2021

Phase I Study of the Efficacy and Safety of Ramucirumab in Combination with Osimertinib in Advanced T790M-positive

Helena A Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.